HDAC9 and neoplasm: In addition to its capability to reduce tumor cell proliferation, the impairment of HDAC activity results in an increased expression of MHC and costimulatory molecules on tumor cell surface, resulting in promoting T cell activation Abrogation of HDAC6 inhibits IL-10 producing myeloid cells, prompting the expansion of inflammatory APCs (145).